Invesco’s Gilead Sciences GILD Stock Holding History

Invesco’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,500	Closed	-$782K	–	3747
2018 Q4	$782K	Hold	12,500	–	–	﹤0.01%	3101
2018 Q3	$965K	Buy	+12,500	New	+$944K	﹤0.01%	3157

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco's GILD Position: Q1 2026 in Review

Invesco reduced its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, selling an estimated $263M and leaving 41,580,823 shares worth $5.8B. The position accounts for 0.57% of the portfolio, ranked #25.

Invesco first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Invesco held 41,580,823 shares of Gilead Sciences worth $5.8B as of Q1 2026.
Invesco sold 1,876,985 Gilead Sciences shares in Q1 2026, an estimated $263M.
Gilead Sciences made up 0.57% of Invesco's portfolio in Q1 2026, its #25 holding.
Invesco first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.